UA102075C2 - Композиція та способи застосування антитіл до склеростину - Google Patents
Композиція та способи застосування антитіл до склеростинуInfo
- Publication number
- UA102075C2 UA102075C2 UAA201003979A UAA201003979A UA102075C2 UA 102075 C2 UA102075 C2 UA 102075C2 UA A201003979 A UAA201003979 A UA A201003979A UA A201003979 A UAA201003979 A UA A201003979A UA 102075 C2 UA102075 C2 UA 102075C2
- Authority
- UA
- Ukraine
- Prior art keywords
- compositions
- methods
- antibodies against
- against sclerostin
- sclerostin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/55—Fab or Fab'
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Винахід належить до антитіла до склеростину, а також до фармацевтичної композиції, що містить зазначене антитіло, та до способу застосування зазначеного антитіла для лікування захворювання, пов'язаного з аномаліями в кістковій тканині, такими як остеопороз.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07118414 | 2007-10-12 | ||
PCT/EP2008/063691 WO2009047356A1 (en) | 2007-10-12 | 2008-10-10 | Compositions and methods for use for antibodies against sclerostin |
Publications (1)
Publication Number | Publication Date |
---|---|
UA102075C2 true UA102075C2 (uk) | 2013-06-10 |
Family
ID=39046845
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UAA201003979A UA102075C2 (uk) | 2007-10-12 | 2008-10-10 | Композиція та способи застосування антитіл до склеростину |
Country Status (1)
Country | Link |
---|---|
UA (1) | UA102075C2 (uk) |
-
2008
- 2008-10-10 UA UAA201003979A patent/UA102075C2/uk unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TN2010000140A1 (en) | Compositions and methods for use antibodies against sclerostin | |
WO2008025020A3 (en) | Cd30 binding agents and uses thereof | |
MY163275A (en) | Ibat inhibitors for the treatment of liver diseases | |
SG10201405377XA (en) | Compositions and methods for antibodies targeting complement protein c5 | |
UA95644C2 (uk) | Піридазинонові похідні, фармацевтична композиція та спосіб лікування захворювань | |
MX2010004219A (es) | Agentes de enlace de cd19 y usos de los mismos. | |
IL195341A (en) | A method of preparing simvastatin and compounds containing simvastatin | |
WO2008027739A3 (en) | Antibodies to ntb-a | |
MX2009008099A (es) | Compuestos para la prevencion y tratamiento de enfermedades cardiovasculares. | |
MX2009012950A (es) | ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS. | |
MX356584B (es) | Analogos de tiazolidindiona para el tratamiento de enfermedad mediada por inflamacion metabolica. | |
MX2018009945A (es) | Composiciones y metodos novedosos para el tratamiento de las enfermedades relacionadas con la inmunidad. | |
EA200970337A1 (ru) | Ингибиторы котранспортера натрий-глюкозы 2 и способы их применения | |
NZ601793A (en) | Methods and compositions for diagnosis and treatment of cancer | |
EA201101475A1 (ru) | Способы применения рецептора gpr119 для идентификации соединений, которые можно использовать для увеличения костной массы субъекта | |
TN2011000528A1 (en) | Compositions and methods for antibodies targeting complement protein c3b | |
MX2012004525A (es) | Compuestos. | |
UA102867C2 (uk) | Антитіла до cxcr4 та їх застосування у лікуванні раку | |
EA200970175A1 (ru) | Способы и композиции для ингибирования ангиогенеза | |
TNSN08370A1 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
WO2009051957A3 (en) | Antibodies to irem-1 | |
EA201070893A1 (ru) | Способы и композиции для лечения заболеваний костей | |
WO2008034142A3 (en) | Synthesis, methods of using, and compositions of cycloalkylmethylamines | |
MX2013001267A (es) | ANTICUERPOS A IL-1ß E EIL-18 PARA TRATAMIENTO DE ENFERMEDAD. | |
TW200744577A (en) | Method for treating osteoarthritis |